Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10064863 | 0.95 | MIF (0.41) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL12958885 | 0.93 | MEN1 (0.41) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL27751009 | 0.89 | MEN1 (0.51) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL3343921 | 0.89 | MGLL (0.44) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL3343916 | 0.89 | MGLL (0.44) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL3343926 | 0.89 | MGLL (0.44) | MGLLMEN1KMT2ACA12CA1 | |
| SCHEMBL13906649 | 0.87 | CA12 (0.47) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL12968216 | 0.87 | PTGES (0.44) | MEN1KMT2ANPC1RAB9ACYP3A4 | |
| SCHEMBL2970560 | 0.86 | BACE1 (0.41) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL2970563 | 0.86 | BACE1 (0.41) | MEN1KMT2ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | ELAN PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | disclosed |
| US-7638646-B2 | Processes and intermediates for preparing benzyl epoxides | ELAN PHARMACEUTICALS INC. (US) | 2009-12-29 | — | — | US | disclosed |
| US-20070299263-A1 | Hydroxy Alkyl Amines | Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | VKORC1, EPOR, POR | MGLL 4098/4885MEN1 1621/4885KMT2A 4391/4885 |
| US-20070299263-A1 | Hydroxy Alkyl Amines | MAOA, PSEN2, PSEN1 | MGLL 2173/4885MEN1 2126/4885KMT2A 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.